These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 38287555

  • 21. Cardiac involvement in anti-MDA5 dermatomyositis: a case-based review.
    Quintero-González DC, Navarro-Beleño K, López-Gutiérrez LV, Muñoz-Urbano M, Vanegas-García AL, Muñoz-Vahos CH.
    Clin Rheumatol; 2023 Mar; 42(3):949-958. PubMed ID: 36454342
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases.
    Horai Y, Isomoto E, Koga T, Okada A, Kawashiri SY, Tamai M, Yamasaki S, Nakamura H, Origuchi T, Hamaguchi Y, Fujimoto M, Kuwana M, Kawakami A.
    Mod Rheumatol; 2013 Jan; 23(1):190-4. PubMed ID: 22460910
    [Abstract] [Full Text] [Related]

  • 24. [Amyopathic dermatomyositis (DM) with anti-MDA5 antibodies, associated with bullous pemphigoid, Sjögren syndrome and gastric MALT lymphoma].
    Garcia B, Dabouz F, Pascal L, Gillard M, Modiano P.
    Ann Dermatol Venereol; 2017 Oct; 144(10):629-633. PubMed ID: 28668260
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
    Zheng S, Chen S, Wu L, Zhao D, Chen F, Zhu J, Li J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul 30; 40(7):1029-1035. PubMed ID: 32895158
    [Abstract] [Full Text] [Related]

  • 27. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y, Fu Q, Wang R, Guo Q, Bao C.
    J Clin Lab Anal; 2019 Oct 30; 33(8):e22978. PubMed ID: 31301087
    [Abstract] [Full Text] [Related]

  • 28. Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease.
    Horino T, Inotani S, Nakajima K, Ohnishi H, Komori M, Terada Y.
    Joint Bone Spine; 2022 Nov 30; 89(6):105456. PubMed ID: 36108903
    [No Abstract] [Full Text] [Related]

  • 29. A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
    Koichi Y, Aya Y, Megumi U, Shunichi K, Masafumi S, Hiroaki M, Masahiko K, Shinsuke K, Manabu U, Kenichiro H, Fumiaki A, Nozomi A, Toshitaka M, Masayoshi Y, Chikako K, Yoshinao M, Tatsuo S, Masahiko K.
    Mod Rheumatol; 2017 May 30; 27(3):536-540. PubMed ID: 25698373
    [Abstract] [Full Text] [Related]

  • 30. Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody.
    Parperis K, Kiyani A.
    BMJ Case Rep; 2018 Jan 04; 2018():. PubMed ID: 29301801
    [Abstract] [Full Text] [Related]

  • 31. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.
    J Rheumatol; 2019 Aug 04; 46(8):935-942. PubMed ID: 31092718
    [Abstract] [Full Text] [Related]

  • 32. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
    Chen X, Zhang L, Jin Q, Lu X, Lei J, Peng Q, Wang G, Ge Y.
    Front Immunol; 2022 Aug 04; 13():987841. PubMed ID: 36110863
    [Abstract] [Full Text] [Related]

  • 33. Autoantibodies against TIF-1-γ and CADM-140 in Spanish patients with clinically amyopathic dermatomyositis (CADM): clinical significance and diagnostic utility.
    Cuesta-Mateos C, Colom-Fernández B, Portero-Sainz I, Tejedor R, García-García C, Concha-Garzón MJ, De las Heras-Alonso ME, Martínez MA, Juarez C, Muñoz-Calleja C.
    J Eur Acad Dermatol Venereol; 2015 Mar 04; 29(3):482-9. PubMed ID: 25065441
    [Abstract] [Full Text] [Related]

  • 34. Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study.
    Zhou S, Lai J, Wu C, Liu Y, Liu Y, Zhao J, Xu D, Tian X, Li M, Zhao Y, Wang Y, Wang Q, Zeng X.
    Front Immunol; 2022 Mar 04; 13():928861. PubMed ID: 35983058
    [Abstract] [Full Text] [Related]

  • 35. Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease.
    Tavakolian K, Odak M, Mararenko A, Ilagan J, Douedi S, Khan T, Al Saoudi G.
    J Med Cases; 2022 Aug 04; 13(8):374-379. PubMed ID: 36128070
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
    Sakamoto N, Ishimoto H, Nakashima S, Yura H, Miyamura T, Okuno D, Hara A, Kitazaki T, Kakugawa T, Ishimatsu Y, Satoh M, Mukae H.
    Intern Med; 2019 Mar 15; 58(6):837-841. PubMed ID: 30449789
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Fatal and extensive multiorgan hemorrhages in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: An autopsy case report.
    Watanabe T, Takizawa N, Nagasaka T, Nakamura Y, Ikai H, Yamamoto M, Murai Y, Takasugi K, Yokoyama-Kokuryo W, Fujita Y.
    Medicine (Baltimore); 2020 Jan 15; 99(3):e18600. PubMed ID: 32011440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.